Unknown

Dataset Information

0

Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.


ABSTRACT: The promotion of colonization with vancomycin-resistant enterococci (VRE) is one potential side effect during treatment of Clostridium difficile-associated diarrhea (CDAD), resulting from disturbances in gut microbiota. Cadazolid (CDZ) is an investigational antibiotic with potent in vitro activity against C. difficile and against VRE and is currently in clinical development for the treatment of CDAD. We report that CDZ treatment did not lead to intestinal VRE overgrowth in mice.

SUBMITTER: Seiler P 

PROVIDER: S-EPMC4704215 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.

Seiler Peter P   Enderlin-Paput Michel M   Pfaff Philippe P   Weiss Maria M   Ritz Daniel D   Clozel Martine M   Locher Hans H HH  

Antimicrobial agents and chemotherapy 20151026 1


The promotion of colonization with vancomycin-resistant enterococci (VRE) is one potential side effect during treatment of Clostridium difficile-associated diarrhea (CDAD), resulting from disturbances in gut microbiota. Cadazolid (CDZ) is an investigational antibiotic with potent in vitro activity against C. difficile and against VRE and is currently in clinical development for the treatment of CDAD. We report that CDZ treatment did not lead to intestinal VRE overgrowth in mice. ...[more]

Similar Datasets

| S-EPMC2897524 | biostudies-literature
| S-EPMC5713723 | biostudies-literature
| S-EPMC6833023 | biostudies-literature
| S-EPMC2693504 | biostudies-literature
| S-EPMC6479037 | biostudies-literature